Chinese Clinical Oncology

764 papers and 5.9k indexed citations i.

About

The 764 papers published in Chinese Clinical Oncology in the last decades have received a total of 5.9k indexed citations. Papers published in Chinese Clinical Oncology usually cover Oncology (319 papers), Pulmonary and Respiratory Medicine (243 papers) and Surgery (174 papers) specifically the topics of Hepatocellular Carcinoma Treatment and Prognosis (68 papers), Lung Cancer Treatments and Mutations (65 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (60 papers). The most active scholars publishing in Chinese Clinical Oncology are Geoffrey Y. Ku, Andrew Lee, Yun Shin Chun, Tomoharu Sugie, Lewis R. Roberts, Peter J. Allen, Ghassan K. Abou‐Alfa, Kah-Whye Peng, Luke Russell and Yoichi Naito.

In The Last Decade

Fields of papers published in Chinese Clinical Oncology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Chinese Clinical Oncology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Chinese Clinical Oncology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Chinese Clinical Oncology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Chinese Clinical Oncology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025